Recruitment - Articles

Almost irrespective of the country you live in, the increasing costs of healthcare are unavoidable. For governments, the stresses are particularly acute, as both aging populations and the increasing cost of treatments add financial pressures year on year. Yet as a new study by the Institute of Fiscal Studies (IFS) confirms, we should not underestimate the extent to which the shape of the state has already changed.
Almost irrespective of the country you live in, the increasing costs of healthcare are unavoidable. For governments, the stresses are particularly acute, as both aging populations and the increasing cost of treatments add financial pressures year on year. Yet as a new study by the Institute of Fiscal Studies (IFS) confirms, we should not underestimate the extent to which the sha…

Certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients after 12 weeks of treatment regardless of whether or not they had received prior TNF inhibitors or whether or not they were receiving concomitant DMARDs, concluded the latest analysis of the Phase III b REALISTIC trial presented at the European League Against Rheumatism (EULAR) meeting in London, May 25-28 (abstract FRI021).
Certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients after 12 weeks of treatment regardless of whether or not they had received prior TNF inhibitors or whether or not they were receiving concomitant DMARDs, concluded the latest analysis of the Phase III b REALISTIC tri…

Want to know which Pharma companies are on Twitter? - here's a list..
I've been keeping track on the pharma companies on Twitter, and the presence and activity varies significantly. Anyway here is the current list for your reference. If you notice any errors or omissions, let me know.  ABPIAccess pharmaActavisAkzonobelAllerganAlnylamAmgenAmgen FoundationAstellas USAstra Zeneca JobsAstraZenecaAstraZeneca - joinastrazenecaAstrazeneca USAstraZenecaNLAzco BiotechAZhelpsBaxterBayerBayer HealthCareBayer JovensBayer PressBayer SanteBayer ScheringBayer SDBayer UK / IrelandBayer US NewsBayer US NewsBayer VitalBayerM SMSBioIndustry AssociationBMS NewsbmsinfoBoehringerBoehringer GermanyBoehringer GreeceBoehringer SpainBoehringer USBoehringernldBristol_MyersDaiichi SankyoDiabetes_sanofiElan…

Since the very dawn of Western capitalism, competition has been synonymous with success. Indeed, in accounting for the past 500 years of Western ascendancy in the world, Professor Niall Ferguson of Harvard University points to six ‘killer apps’. The first of these, unsurprisingly, is competition
Since the very dawn of Western capitalism, competition has been synonymous with success. Indeed, in accounting for the past 500 years of Western ascendancy in the world, Professor Niall Ferguson of Harvard University points to six ‘killer apps’. The first of these, unsurprisingly, is competition. However in the world of healthcare, this theory has faced more than its fair share of criticism. Doubtless, few sensible men would argue that healthcare has not benefitted from the entrepreneurial pressur…

Earlier this month the UK drugs giant GlaxoSmithKline announced a groundbreaking and progressive new scheme for graduates, whereby from 2012 the company will offer to reimburse in full the university tuition fees of the entirety its future graduate intake.
In the final months of 2010, the subject of student tuition fees dominated our political discourse. What originated as relatively civil and contained acts of protest quickly mutated into angry and ultimately violent conflict at the heart of Britain’s capital city. The bellowing voice of extremism had once again drowned out the silent minority and images of discord and chaos dominated our television screens. At the zenith of the violence, the London headquarters of the Conservative Party was attacked, destroying the building’s main lobby…

After six months of sometimes lively pursuit, the French pharmaceutical group, Sanofi-aventis, has agreed a deal to pay $20.1bn in cash for U.S. biotech firm Genzyme Corp after Sanofi made an increased offer of $74 per share.
Once completed, the deal will represent the biggest pharmaceutical takeover since 2009 and the largest acquisition by the group since its $50bn purchase of Aventis back in 2004. In view of excited predictions from Genzyme executives on potential sales of Lemtrada (alemtuzumab), each share will also be linked to tradable Contingent Value Rights (CVRs) worth up to $14 a share if all performance milestones are reached. While Genzyme predicts sales for Lemtrada approaching $3.5bn, Sanofi has been somewhat more reserved in its estimates. While payments mainly depend on th…

Out there on the branding battlefields its simply do or die as brand images are either hyper visible or mortally lost in oblivion. Commanding success for any idea on the global scene demands universal access on e-commerce that is only deliverable by a cyber name identity, as it's the only key to open the site.
Out there on the branding battlefields its simply do or die as brand images are either hyper visible or mortally lost in oblivion. Commanding success for any idea on the global scene demands universal access on e-commerce that is only deliverable by a cyber name identity, as it's the only key to open the site. Without it, accessibility to any cyber empire is simply doomed, dragging expansion dreams into cyber oblivion. Millions of million-dollar websites have slipped into the abyss,…

The Kingdom of Saudi Arabia provides a new opportunity for clinical research, and can open doors to untapped populations, explains Rani Abraham at ClinTec International
Recently, there has been a definite increase in the potential for investment in the clinical trials sector in the Kingdom of Saudi Arabia (KSA). Certain reforms in the sector such as the establishment of the Saudi Food and Drug Authority (SFDA)and the growth of the local pharmaceutical and healthcare industries, in combination with the growing importance of data from different races or ethnic populations, have made KSA an attractive country for conducting clinical trials. In the last decade, ethnicity and socio-economic differences in relation to disease incidence, diagnosis and prognosis have attracted attention. The inclus…

There has been some conjecture amongst professionals regarding the merits of a personal profile on a CV. This conjecture stems from the fact that many job seekers fill there personal profiles with irrelevant and mostly clichéd information.
There has been some conjecture amongst professionals regarding the merits of a personal profile on a CV. This conjecture stems from the fact that many job seekers fill there personal profiles with irrelevant and mostly clichéd information. Here at the CV & Interview Advisors, we offer free CV Appraisals, therefore see hundreds of CVs per week. I recently reviewed 5 CVs back-to-back and was interested to find that all 5 people considered themselves to be dynamic and innovative with excellent communication skills. Having spoken to all 5 individuals, it…

In my capacity as a Career Consultant, I have worked closely with freelancers & contractors for many years and two challenges keep rearing their ugly head: Firstly, how does a freelancer write a CV that isn’t six pages long; and secondly, what happens if you want to apply for a role that draws upon skills gained in a contract that isn’t the most recent piece of work that you have done.
In my capacity as a Career Consultant, I have worked closely with freelancers & contractors for many years and two challenges keep rearing their ugly head: Firstly, how does a freelancer write a CV that isn’t six pages long; and secondly, what happens if you want to apply for a role that draws upon skills gained in a contract that isn’t the most recent piece of work that you have done. I anticipate lots o…

The role of a seasoned pharmacist has some obvious kind of benefits attached with it. This basically includes the role that they play and the kind of work carried out by them including learning the trade from a well-known lead pharmacist.
The role of a seasoned pharmacist has some obvious kind of benefits attached with it. This basically includes the role that they play and the kind of work carried out by them including learning the trade from a well-known lead pharmacist. The first step in this career is that of a technician that grows further until one becomes a lead pharmacist in a reputed organization. Since these pharmacist start out as complete strangers offering medicines to the patients prescribed by the doctor or physician their role becomes extremely crucial within the healthcare…

We have a fundamental problem with our health service. It's bloated, it's weighed down in bureaucracy and it's terribly inefficient. That's if you believe the diagnosis of our health service by the new Health Secretary, Andrew Lansley.
We have a fundamental problem with our health service. It's bloated, it's weighed down in bureaucracy and it's terribly inefficient. That's if you believe the diagnosis of our health service by the new Health Secretary, Andrew Lansley. Indeed, not only is our health service inefficient, but it is incredibly disconnected from the people it’s meant to serve - the patients. For these reasons and others, Mr. Lansley is proposing the biggest shake-up of the health service in 60 years. 'Our guiding principle', Mr. Lansley says, will be ‘no decision about me, witho…

During a time of major economic downturn, there are few industries that can be said to be truly ‘recession proof’. Yet for years now, big pharma has largely been seen as precisely that. After all, no matter dire the markets, and no matter how low consumer confidence plummets, there is always a demand for healthcare.
During a time of major economic downturn, there are few industries that can be said to be truly ‘recession proof’. Yet for years now, big pharma has largely been seen as precisely that. After all, no matter dire the markets, and no matter how low consumer confidence plummets, there is always a demand for healthcare. Seen from this angle then, it’s almost as good as mandatory spending. Yet as the most recent global economic slowdown has shown, healthcare and big pharma aren’t qu…

Economic uncertainty has fueled a growing trend toward self-employment and entrepreneurialism with one-in-five respondents worldwide now working outside the traditional employment relationship, and 50 percent saying that they would like to do so, according to the latest survey results from workforce solutions leader Kelly Services®.
The findings are part of the Kelly Global Workforce Index, which obtained the views of approximately 134,000 people in 29 countries across North America, Europe, and Asia Pacific. The rise of the self-employed, often known as independent contractors or ‘free agents,’ is most pronounced in North America, with 26 percent identifying themselves in this category, compared with 19 percent in Asia Pacific, and 17 percent in Europe. The survey also fin…

Thousands of Brits waste time and energy searching for new jobs every winter, because they fail to differentiate between seasonal blues and job dissatisfaction.
According to business consultant Lindsay Rutland-Dix, the way to separate the two is to ask a few simple questions at the first signs of office demotivation. “It’s easy to feel run-down and fed-up after such a cold, dark and depressing winter, but you have to be careful not to let this cloud your judgment,” says Rutland-Dix. “Before you do anything drastic, ask yourself whether jumping ship is really what you want. If you’ve simply fallen into a seasonal slump, you need to recognise that you do love what you do – and throw yourself back into it.” Rutland-Dix, who is a Master Practitioner of Neuro Linguistic Programming, has devi…

‘You really need some more experience’. Perhaps the most ubiquitous phrase in modern day recruitment, thousands of graduates are now at the mercy of this one requirement as increasing competition in the job market leads to rising standards. Perhaps twenty, or even ten years ago, an undergraduate degree and a forceful sense of charisma might well have been enough to net you your first role in an industry.
‘You really need some more experience’. Perhaps the most ubiquitous phrase in modern day recruitment, thousands of graduates are now at the mercy of this one requirement as increasing competition in the job market leads to rising standards. Perhaps twenty, or even ten years ago, an undergraduate degree and a forceful sense of charisma might well have been enough to net you your first role…

Keynes called it an ‘inducement to invest’. In this instance, the most recent financial crisis has called for many of the same approaches used in the 1930s to stimulate the economy and bring industries back to their feet. Today more than ever, we realize that education is one of the most decisive facets of any successful stimulus.
A Call to Arms: Keynes called it an ‘inducement to invest’. In this instance, the most recent financial crisis has called for many of the same approaches used in the 1930s to stimulate the economy and bring industries back to their feet. Today more than ever, we realize that education is one of the most decisive facets of any successful stimulus. That’s why, alongside a whole host of other policies and schemes, the Economic Challenge Investment Fund (ECIF) manag…

At what point does a conflict of interests occur? Last year – and for many years before that – U.S. drugs companies paid out tens of millions of dollars in payments and gifts to physicians and academics. Earlier this year, the Pharmaceutical and Research Manufacturers of America (PhRMA) released a revised, and somewhat toughened, code of practice.
Some Background: At what point does a conflict of interests occur? Last year – and for many years before that – U.S. drugs companies paid out tens of millions of dollars in payments and gifts to physicians and academics. Earlier this year, the Pharmaceutical and Research Manufacturers of America (PhRMA) released a revised, and somewhat toughened, code of practice. Their attempts to target the flow of payments and gifts to doctors has resulted…

We're having a fascinating day at the Financial Times Global Pharmaceutical and Biotechnology conference on London.
One of the most interesting commentaries today came from Jean-Luc Bélingard, CEO of Ipsen. Jean-Luc stated that in his view, for the pharmaceutical segment, ‘Demand is infinite’ – with no therapeutic cure for the mahority of diseases. Take diabetes for example – we can treat it, to a large extent, but we can’t cure it. This makes the pharma and interesting market, and this, with all of the other changes and challenges in the segment, does pose challenges for the survival and growth of individual pharmaceutical corporates. Paul Hartigan, CEO of PharmiWeb Solutions, asked Jean-Luc if he was confident therefore in the future for the industry. (Mr Bélingard started his career at…

Weekly Swine Flu Update for the Week Ending November 1st.
The past few weeks have been something of a medical paradox. Yes, the number of cases is increasing, but it is doing so somewhat more steadily than first anticipated. The full brunt of the highly anticipated ‘second wave’ is more likely to come towards the end of December and into the heat of the winter season. Conversely, while there hasn’t been a terrible spike in the number of cases, more people are being hospitalized with the virus. Hospitals too are beginning to feel the strain. Speaking on BBC 1’s the Andrew Marr Show, the UK’s Chief Medical Officer, Sir. Liam Donaldson said "What we are seeing is that while most people generally get a mild illness, a small proportion of people are getting very serious illnesses”. And while…